Mead Johnson Nutrition Co (MJN): Jobe Continues to Sell

0

James J. Jobe, Senior Vice President and Technical Operations at Mead Johnson Nutrition Co (NYSE:MJN) disclosed today the disposal of 13,956 shares of common stock through two separate transactions on October 27, 2014. The first transaction involved 6,355 shares, previously acquired through a right to buy option at a unit price of $26.58, and sold at $101.9 per unit. The remaining 7,601 shares were sold at a unit price of $101.8931. This is Mr. Jobe’s first sale this year, and now directly owns a total 8,501 shares and an additional 54 indirectly.

Stephen W. Golsby, Director at Mead Johnson Nutrition Co (NYSE:MJN) also disposed of some stock.  Mr. Golsby sold a total of 204,452 shares, at prices ranging from $82.44 to $96.43, through thirteen transactions since January of this year.

Ken Griffin’s Citadel Investment Group is the largest shareholding institutions (amongst those we track) at Mead Johnson Nutrition Co (NYSE:MJN) with 2,037,471 shares, valued at an estimate $190 million, after reporting an 11% stock reduction for the second filling period of 2014.

Mead Johnson Nutrition Co (NYSE:MJN) is a global pediatric nutrition company that manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products.

Disclosure: The author, Jodor Jalit, holds no position in any stocks or funds mentioned.

Suggested Articles:

 Strategies Hedge Funds Use to Make Huge Returns

Most Expensive Boats In the World

Share.

Leave A Reply